Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
A new compound removes senescent cells and reduces toxicity in cancer treatment
The accumulation of senescent cells plays a significant role in cancer pathogenesis and other diseases.…
Gene research could push cancer research forward
New research by scientists at the Australian National University (ANU) will help us better understand…
One-week course of radiotherapy could benefit women with early stage breast cancer, study finds
A one-week course of radiotherapy in fewer but larger daily doses was found to be…
Do Wi-Fi and mobile phones really cause cancer? Experts respond
By Simon Chapman, University of Sydney; Darren Saunders, UNSW Australia; Rodney Croft, University of Wollongong, and Sarah Loughran, University of Wollongong.…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.